Skip to main content
 

Florence Mahoney Lecture on Aging

Sponsored by the National Institute on Aging, the series recognizes Mrs. Mahoney’s lifetime commitment to medical research and its benefits to people worldwide. Florence Stephenson Mahoney is widely known for her dedicated efforts in shaping national health science policy, particularly with respect to aging.

Stem cells, aging, and aging stem cells

April 5, 2017 -
3:00pm to 4:00pm
Amy Wagers, Ph.D. , Harvard University

The information for this lecture has not yet been made available. Please check back soon for an updated overview.

Age, genes, sex, and smell: predicting Parkinson disease

May 4, 2016 -
3:00pm to 4:00pm
Andrew Singleton, Ph.D. , National Institute on Aging

Dr. Singleton's talk will focus on the most effective route to testing disease-modifying therapies in neurodegenerative disease earlier in the disease process, with a particular focus on Parkinson disease. He will discuss attempts to make headway in identifying at-risk patients as early as possible in the disease process, when interventions may be most effective.

A multiscale biology approach for dissecting the complex processes underlying aging and aging related phenotypes

October 1, 2014
Eric Schadt, Ph.D., Mount Sinai

The annual Mahoney Lecture is named in honor of Florence Stephenson Mahoney (1899–2002), who devoted the last half of her life to successfully advocating for the creation of the National Institute on Aging and increased support for NIH. During his lecture, Dr. Schadt will focus on the integration of the digital universe of information to better diagnose, treat, and prevent human disease. The lecture will feature the work of Dr.

Epigenetic regulation of senescence and aging

March 12, 2014
Shelley L. Berger, Ph.D., University of Pennsylvania Perelman School of Medicine

Aging is a crucial risk factor in a constellation of human diseases, including cancer and neurodegenerative diseases. Along with other risk factors such as environmental exposures, diet, behavior, and heredity, these risks can be understood through their impact on the epigenetic landscape in ways that ultimately lead to the burden of disease. Among these risks, aging had been regarded as fixed, but current thinking holds that aging is plastic and its pace can be slowed or even reversed. Dr.


The page was last updated on Thursday, January 29, 2015 - 2:31pm